The Medline Agreement establishes a multi-year framework for supply and co-development activities, including manufacturing scale-up for our PermaFusion-based formulations
The majority of our accounts payable and accrued expenses are concentrated with one vendor having a balance of approximately $ 1.2 million which represents approximately 53 % of our accounts payable …
For medical device applications of GX-03, including GX-03 impregnated gauze, we utilize in-house sterilization services provided by SCAPA via gamma irradiation (GAMMA)
Turn Therapeutics Inc. Customers
No clients on recordNo downstream customers found in our database for Turn Therapeutics Inc..
Turn Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TTRX-DEBT
Debt stack $6.0M
90%
Market cache reports total debt of $6.0M.
TTRX-DEBT-20644
Warrants outstanding: 1192207
90%
xbrl warrant detail from xbrl 2026-03-31.
Turn Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Turn Therapeutics Inc..
Turn Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
TTRX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 20 tracked holders.
Turn Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
